Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
269 words
In a method for volumetrically differentiating leukocytes in a whole blood sample into three subpopulations, identified as lymphocyte, neutrophilic granulocyte and infrequent and rare leukocyte subpopulations, using an atomatic particle analyzing system, said method comprising the steps of: (a) supplying a whole blood sample, a volume of diluent suitably balanced for maintaining cell size in the whole blood sample, and a volume of a lysing reagent to an automatic particle analyzing system; (b) mixing the whole blood sample with the diluent and the lysing reagent in the automatic particle analyzing system in such a manner as to enable enumeration of the lymphocyte and neutrophilic granulocyte subpopulations in the whole blood sample and to enable quantitative evaluation of the infrequent and rare leukocyte subpopulation in the whole blood sample; and (c) using the automatic particle analyzing system to enumerate the lymphocyte and neutrophilic granulocyte subpopulations in the whole blood sample and to quantitatively evaluate the infrequent and rare leukocyte subpopulation in the whole blood sample; wherein the improvements comprise: using a diluent containing cell-stabilizing 1,3-dimethylurea and using a lysing agent consisting of 55-150 ml of a 50% (w/v) solution of a single, intrinsically gentle, quaternary ammonium salt, up to 4 g of potassium cyanide, and sufficient water to make one liter, wherein the quaternary ammonium salt is selected from the group consisting of salts having the general formula: ##STR2## wherein R 1 , R 2 and R 3 are short-chain alkyl groups having one to four carbons, R 4 is a twelve-carbon alkyl group, and X is a cation selected from the group consisting of halides, sulfates, nitrates, and phosphates.
Claim 2
Dependent Claim
269 words
In a method for volumetrically differentiating leukocytes in a whole blood sample into three subpopulations, identified as lymphocyte, neutrophilic granulocyte and infrequent and rare leukocyte subpopulations, using an atomatic particle analyzing system, said method comprising the steps of: (a) supplying a whole blood sample, a volume of diluent suitably balanced for maintaining cell size in the whole blood sample, and a volume of a lysing reagent to an automatic particle analyzing system; (b) mixing the whole blood sample with the diluent and the lysing reagent in the automatic particle analyzing system in such a manner as to enable enumeration of the lymphocyte and neutrophilic granulocyte subpopulations in the whole blood sample and to enable quantitative evaluation of the infrequent and rare leukocyte subpopulation in the whole blood sample; and (c) using the automatic particle analyzing system to enumerate the lymphocyte and neutrophilic granulocyte subpopulations in the whole blood sample and to quantitatively evaluate the infrequent and rare leukocyte subpopulation in the whole blood sample; wherein the improvements comprise: using a diluent containing cell-stabilizing 1,3-dimethylurea and using a lysing agent consisting of 55-150 ml of a 50% (w/v) solution of a single, intrinsically gentle, quaternary ammonium salt, up to 4 g of potassium cyanide, and sufficient water to make one liter, wherein the quaternary ammonium salt is selected from the group consisting of salts having the general formula: ##STR2## wherein R 1 , R 2 and R 3 are short-chain alkyl groups having one to four carbons, R 4 is a twelve-carbon alkyl group, and X is a cation selected from the group consisting of halides, sulfates, nitrates, and phosphates.
Claim 3
Dependent Claim
44 words
The method of claim 1 wherein said quaternary ammonium salt is a member selected from the group consisting of dodecyltrimethyl ammonium chloride, dodecyltrimethyl ammonium bromide, dodecyltrimethyl ammonium fluoride, dodecyltrimethyl ammonium sulfate, dodecyldimethylethyl ammonium chloride, dodecyldimethylethyl ammonium fluoride, dodecyldimethylethyl ammonium bromide, and dodecyldimethylethyl ammonium sulfate.
Claim 4
Dependent Claim
14 words
The method of claim 1 wherein said quaternary ammonium salt is dodecyltrimethyl ammonium chloride.
Claim 5
Dependent Claim
47 words
The method of claim 1 wherein said diluent comprises: (a) said 1,3-dimethylurea; (b) an organic buffer; (c) a bacteriostatic agent; (d) an inorganic salt to correct conductivity, ionic strength and osmolality in the whole blood sample; (e) a suitable additional alkali for pH optimization; and (f) water.
Claim 6
Dependent Claim
23 words
The method of claim 4 wherein said inorganic salt is a member selected from the group consisting of sodium chloride and sodium sulfate.
Claim 7
Dependent Claim
49 words
The method of claim 4 wherein said organic buffer is a member selected from the group consisting of ADA [N-(2-acetamido)-2-iminodiacetic acid; N-(carbamoylmethyl)iminodiacetic acid], MOPS [3-(N-Morpholino)propane sulfonic acid], PIPES [piperazine-N,N'-bis(2-ethanesulfonic acid); 1,4-piperazinediethanesulfonic acid], HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid], BES [N,N-bis(2-hydroxyethyl)2-aminoethanesulfonic acid; 2-(bis(2-hydroxy-ethyl)-amino)ethanesulfonic acid], BIS-TRIS [bis(2-hydroxy-ethyl)imino-tris-(hydroxymethyl)methane; 2-bis(2-hydroxy-ethyl)amino-2-(hydroxy-methyl)-1,3-propanediol] and TES [(N-tris(hydroxymethyl)-methyl-2-aminoethane-sulfonic acid); 2-((2-hydroxy-1,1-bis(hydroxymethyl)ethyl)aminoethanesulfonic acid)].
Claim 8
Dependent Claim
11 words
The method of claim 4 wherein said bacteriostatic agent is 1-hydroxypyridine-2-thione.
Claim 9
Dependent Claim
16 words
The method of claim 4 wherein said suitable additional alkali for pH optimization is sodium hydroxide.